After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
NBIX belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Neurocrine Biosciences, Inc is $11.41B. A total of 0.97 million shares were traded on the day, compared to an average of 1.29M shares.
In the most recent transaction, Cooke Julie sold 1,551 shares of NBIX for 116.78 per share on Feb 13 ’25. After the transaction, the Chief Human Resources Officer now owns 19,544 company shares. In a previous transaction on Feb 13 ’25, GORMAN KEVIN CHARLES sold 5,844 shares at 116.69 per share. NBIX shares that Director owns now total 521,618.
Among the insiders who sold shares, SHERWIN STEPHEN A disposed of 13,831 shares on Feb 13 ’25 at a per-share price of $116.69. This resulted in the Director holding 10,673 shares of NBIX after the transaction. In another insider transaction, ROBERTS EIRY sold 1,718 shares at $116.85 per share on Feb 13 ’25. Company shares held by the Chief Medical Officer now total 34,252.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NBIX has a high of $157.98 and a low of $105.18.
As of this writing, NBIX has an earnings estimate of $1.32 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of $1.82 per share and a lower estimate of $0.91.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NBIX’s latest balance sheet shows that the firm has $711.30M in Cash & Short Term Investments as of fiscal 2021. There were $440.40M in debt and $245.80M in liabilities at the time. Its Book Value Per Share was $26.05, while its Total Shareholder’s Equity was $1.37B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NBIX is Buy with a score of 4.62.
